KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $33,342,000 | +3512.4% | 185,421 | +1983.9% | 0.03% | +3000.0% |
| Q2 2017 | $923,000 | +54.6% | 8,898 | +17.0% | 0.00% | 0.0% |
| Q1 2017 | $597,000 | +26.5% | 7,605 | -17.9% | 0.00% | – |
| Q4 2016 | $472,000 | +31.8% | 9,262 | +44.6% | 0.00% | – |
| Q3 2016 | $358,000 | +11.9% | 6,405 | 0.0% | 0.00% | – |
| Q2 2016 | $320,000 | +2185.7% | 6,405 | +2056.6% | 0.00% | – |
| Q1 2016 | $14,000 | -22.2% | 297 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | -82.0% | 297 | -83.5% | 0.00% | – |
| Q3 2015 | $100,000 | -92.8% | 1,797 | -92.1% | 0.00% | -100.0% |
| Q2 2015 | $1,389,000 | +2.6% | 22,781 | -2.9% | 0.00% | 0.0% |
| Q1 2015 | $1,354,000 | +515.5% | 23,453 | +514.8% | 0.00% | – |
| Q4 2014 | $220,000 | +165.1% | 3,815 | +30.6% | 0.00% | – |
| Q3 2014 | $83,000 | – | 2,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |